Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Nexstim: Stimulating Earnings Turnaround

By Inderes
Nexstim

Nexstim is a medical technology company, whose transcranial magnetic stimulation technology is used in pre-operative brain mapping and to treat neurological diseases and disorders. This technologically advanced niche player has a commercialization in relatively early stages and has been loss-making throughout its history. This year we expect a profitable result, supported by a non-recurring license fee. Analyst Antti Siltanen guides through technology, income streams, business model, future outlook and valuation.

Content:
00:00 Introduction
00:12 Technology and innovation
03:06 How does the technology work?
04:31 Customers, business idea and income streams
05:50 Regulation, R&D, and approval of the technology
07:48 Company history
10:00 Business segments + new openings with technology licensing
13:45 Pros, cons and restrictions regarding the licensing deal with Magnus medical
17:31 Joint ventures with TMS clinics in the US
19:10 The nature of the investment in the clinic
20:07 Sales in detail
21:22 Sales organization
22:08 Potential and cost structure
23:27 Valuation
27:15 H1’22 comments

Graphics: Inderes and Nexstim

Read the latest research, published 2022-08-16:
https://www.inderes.se/research/stimulating-earnings-turnaround

Read more about Nexstim: https://www.inderes.se/companies/Nexstim

Recent videos

Orion as an Investment | Life Science Night Dec. 9, 2025
2025-12-13 12:50 Orion
A sit-down with CEO Remco Westermann
2025-12-12 09:09 Verve Group
Aiforia as an Investment | Life Science Night Dec 9, 2025
2025-12-11 11:00 Aiforia Technologies
Endomines as an Investment | Investor Day Nov. 24, 2025
2025-12-10 12:30 Endomines Finland
Clas Ohlson, Audiocast, Q2'25
2025-12-10 09:00 Clas Ohlson
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.